0.00Open0.00Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover0.01%IV-150.00%PremiumJan 17, 2025Expiry Date10.50Intrinsic Value100Multiplier23DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-1.0000Delta0.0000Gamma0.67Leverage Ratio0.0000Theta0.0000Rho-0.67Eff Leverage0.0000Vega
Silence Therapeutics Stock Discussion
Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
Silence Therapeutics presented additional Phase 1 results for divesiran in polycythemia vera (PV) patients at the ASH Annual Meeting. The SANRECO study data showed substantial reduction in phlebotomy frequency and lower hematocrit levels in 19 PV patients. Following treatment, only five phlebotomies were required during t...
$Rezolve AI (RZLV.US)$ Alot of short shares sold this month and in September. Reversal should be starting now that it has reached $1.63. First climb will be to 4.70 with that PT being at the end of December. February's PT will be 12.00. Partnerships with Microsoft and Google will push it until they re...
No comment yet